West Virginia Code of State Rules
Agency 11 - Medicine
Title 11 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF MEDICINE
Series 11-08 - Collaborative Pharmacy Practice
Section 11-8-3 - Requirements for Collaborative Pharmacy Practice
Current through Register Vol. XLI, No. 38, September 20, 2024
3.1. Pharmacists and physicians may engage in collaborative pharmacy practice in accordance with the provisions of this rule.
3.2. Collaborative pharmacy practice may only occur:
3.3. A physician's eligibility to serve as a collaborating physician may be verified through information available on the websites of the Board of Medicine and Board of Osteopathic Medicine. Physicians who are eligible to collaborate with pharmacists shall ensure that pharmacy collaboration remains within:
3.4. The Board of Pharmacy shall verify a pharmacist's eligibility to enter into collaborative pharmacy practice agreements upon receipt of an eligibility verification request which is accompanied by satisfactory documentation that the pharmacist:
3.5. Eligible pharmacists and physicians may enter into collaborative pharmacy practice agreements in any practice setting. Collaborative pharmacy practice agreements must contain all required elements set forth in section 4 of this rule.
3.6. Prior to commencing practice pursuant to a collaborative pharmacy practice agreement, the parties shall file a complete practice notification with the Board of Pharmacy.
3.7. A practice notification shall be submitted on a form approved by the boards and shall be accompanied by a $50 fee payable to the Board of Pharmacy. The practice notification form shall be published on the boards' websites.
3.8. A practice notification shall include:
3.9. A complete practice notification is effective upon filing, remains valid until the collaborative pharmacy practice agreement terminates, and is not subject to renewal or renewal fees.
3.10. The boards shall acknowledge receipt of all practice notifications. If a practice notification is incomplete or appears to be invalid, the Board of Pharmacy shall contact the collaborating pharmacist about any issue of validity and any information needed to complete the practice notification. The Board of Pharmacy may request the assistance of the Board of Medicine or the Board of Osteopathic Medicine to evaluate or respond to any issues of practice notification completeness or validity.
3.11. Within five business days of receiving a complete, valid practice notification, the Board of Pharmacy shall confirm receipt to the collaborating pharmacist and provide a copy of the practice notification to the collaborating physician's licensing board. Within five days of receipt of the practice notification from the Board of Pharmacy, the Board of Medicine or Board of Osteopathic Medicine shall notify the collaborating physician.
3.12. The boards shall maintain a current list of all practice notifications for collaborative pharmacy practice agreements.